Journal of Pharmacopuncture (대한약침학회지)

KOREAN PHARMACOPUNCTURE INSTITUTE (대한약침학회)
권호 표지
DOI QR코드

DOI QR Code

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis

류마티스 관절염에 있어 종양괴사인자 다형성에 대한 연구

  • Kim, Kyung-Un (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University) ;
  • Lee, Kyung-Min (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University) ;
  • Lee, Bong-Hyo (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University) ;
  • Lim, Seong-Chul (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University) ;
  • Jung, Tae-Young (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University) ;
  • Seo, Jung-Chul (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Dageu Haany University)
  • 김경운 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 이경민 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 이봉효 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 임성철 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 정태영 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 서정철 (대구한의대학교 한의과대학 침구경혈학교실)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Tumor necrosis factor-${\alpha}{\cdot}$(TNF-${\alpha}{\cdot}$) is a proinflammatory cytokine involved in the pathogenesis of rheumatoid arthritis. This study was designed to investigate the relation between TNF-${\alpha}{\cdot}$ gene polymorphism and rheumatoid arthritis in Korean population. Methods : This study was carried out on 103 rheumatoid arthritis patients who fulfilled the American College of Rheumatology 1987 revised criteria for rheumatoid arthritis and 208 healthy control subjects. Blood samples from all subjects were obtained for DNA extraction. The extracted DNA was amplified by polymerse chain reaction(PCR). PCR products were visualized by 2% agarose gel electrophoresis. We investigated the genotyping of TNF-${\alpha}{\cdot}$ by using Pyrosequencing. Results : The genotypes of TNF-${\alpha}{\cdot}$ gene were GG, AG and AA. While the distribution of TNF-${\alpha}{\cdot}$ polymorphism in control subjects was 92.31%, 7.21%, 0.48% respectively, in rheumatoid arthritis patients was 93.20%, 6.80%, 0.00%(GG, AG. AA). There was no statistical significant allelic frequency difference between control and rheumatoid arthritis groups. Conclusion : We concluded that there was no significant association between TNF-${\alpha}{\cdot}$ gene polymorphism and rheumatoid arthritis. However, the findings of this study need to be confirmed in more patients and further studies.

Keywords

References

  1. 윤지희. Immune Responses in Rheumatoid Arthritis. 분자세포생물학뉴스. 2002;14(4):7-12
  2. 張仲景. 金櫃要略. 서울:大星文化社. 1993:12-4, 30-9
  3. 金定濟. 診療要鑑. 서울:東洋醫學硏究所. 1974:459-60
  4. 顧伯華. 實用中醫外科學. 上海:上海科學技術出版社. 1985:385-9
  5. 권재식, 김기현, 김형태, 박응호, 서성훈. 痺證. 서울:정담. 1993: 29, 208-10, 214
  6. 董綮明. 實用中醫內科學. 上海:上海科學技術出版社. 1986:554-69
  7. 권영달, 송용선. 류마티스 관절염에 대한 동서의학적 고찰. 대한한의학회지. 1994;15(2):373-96
  8. 張介賓. 經岳全書. 北京:人民衛生出版社. 1991:248-55
  9. 巢元方. 巢氏諸病源候論. 台北:昭人出版社. 1974:19
  10. Moreland LW. Inhibitors of tumor necrosis factor for rheumatoid arthritis. J Rheumatol Suppl. Rheumatol. 1999;57:7-15
  11. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440 https://doi.org/10.1146/annurev.immunol.14.1.397
  12. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor(p75)-Fc fusion protein. N Engl J Med. 1997;337:141-7 https://doi.org/10.1056/NEJM199707173370301
  13. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253-9 https://doi.org/10.1056/NEJM199901283400401
  14. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet. 1999;354:1932-9 https://doi.org/10.1016/S0140-6736(99)05246-0
  15. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC, Medeiros R. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun. 2005;334(2):558-92 https://doi.org/10.1016/j.bbrc.2005.06.137
  16. Gupta V, Sarin BC, Changotra H, Sehajpal PK. Association of G-308A TNF-alpha polymorphism with bronchial asthma in a North Indian population. J Asthma. 2005;42(10):839-41 https://doi.org/10.1080/02770900500370924
  17. Densem CG, Hutchinson IV, Yonan N, Brooks NH. Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart. 2002;87:153-5 https://doi.org/10.1136/heart.87.2.153
  18. 안병용, 김경아, 남혜윤, 문제혁, 정진숙, 임영. 탄광부 진폐증의 진행에 있어 TNF-${\alpha}$ 유전자 다형성의 역할. 대한산업의학회지. 2002;14(2):117-23
  19. Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Wu CC, Liu HW. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol. 2001;;28(8):1788-92
  20. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol. 1997;36(5):516-21 https://doi.org/10.1093/rheumatology/36.5.516
  21. Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G, Rodriguez-Perez JM, Perez-Hernandez N, Montes de Oca JV, Cardiel MH, Granados J, Vargas-Alarcon G. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun. 2005;24(1):63-8 https://doi.org/10.1016/j.jaut.2004.11.002
  22. Fabris M, Di Pe, D'Elia A, Damante G, Sinigaglia L, Ferraccioli G. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol. 2002;29:29-33
  23. Amett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24 https://doi.org/10.1002/art.1780310302
  24. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-30 https://doi.org/10.1126/science.274.5292.1527
  25. http://www.pyrosequencing.com
  26. Gruber JD, Colligan PB, Wolford JK. Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing. Hum Genet. 2002;110:395-401 https://doi.org/10.1007/s00439-002-0722-6
  27. Pettersson M, Bylund M, Alderborn A. Molecular haplotype determination using allele-specific PCR and pyrosequencing technology. Genomics. 2003;82:390-6 https://doi.org/10.1016/S0888-7543(03)00177-0
  28. Pacey-Miller T, Henry R. Single-nucleotide polymorphism detection in plants using a single-stranded pyrosequencing protocol with a universal biotinylated primer. Anal Biochem. 2003;317:166-70 https://doi.org/10.1016/S0003-2697(03)00089-7
  29. Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet. 2001;28(1):89-93 https://doi.org/10.1046/j.1365-2370.2001.00233.x
  30. van der Borght A, Geusens P, Raus J, Stinissen P. The autoimmune pathogenesis of rheumatoid arthritis:role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum. 2001;31:160-75 https://doi.org/10.1053/sarh.2001.27736
  31. Smith JB, Haynes MK. Rheumatoid arthritis:a molecular understanding. Ann Intern Med. 2002;136:908-22 https://doi.org/10.7326/0003-4819-136-12-200206180-00012
  32. Genevay S, di Giovine FS, Perneger TV, Silvestri T, Stingelin S, Duff G, Guerne PA. Assosiation of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum. 2002;47:303-9 https://doi.org/10.1002/art.10394
  33. Verhoef CM, van Roon JA, Vianen ME, Bijlsma JW, Lafeber FP. interleukin-gamma production, correlates with progression of joint destruction in rheumatoid arthritis. J Rheumatol. 2001;28:1960-6
  34. 王琦. 黃帝內經素問今釋. 서울:成輔社. 1983:206, 209
  35. Abboud HE. Growth factors in glomerulonephritis. Kidney Int. 1993;43:252-67 https://doi.org/10.1038/ki.1993.39
  36. Ribbens C, Andre B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG. Increased synovial fluid levels of interlukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. Eur Cytoine Netw. 2000;11:669-76
  37. Czaja AJ, Cookson S, Contantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphism assocated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117:645-52 https://doi.org/10.1016/S0016-5085(99)70458-0
  38. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class Ⅱ-associated differences in production of tumor necrosis factor alpha:relevance to genetic predisposition to systemic lupus erythematous. Proc Natl Sci USA. 1990;87:1233-7 https://doi.org/10.1073/pnas.87.3.1233
  39. Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobson B, Odum N, Svejgaard A. Association between HLA-DR2 and production of tumor necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scan J Immunol. 1998;28:599-606 https://doi.org/10.1111/j.1365-3083.1988.tb01492.x
  40. Probert L, Selmaj K. TNF and related molecules;trends in neuroscience and clinical application. J Neuroimmunol. 1996;72:113-7 https://doi.org/10.1016/S0165-5728(96)00176-2